What is Onglyza?
Onglyza (generic: saxagliptin) is designed to be used along with diet and exercise to lower blood sugar levels in patients with type 2 diabetes. Saxagliptin is in a class of medications called dipeptidyl peptidase-4 (DPP-4) inhibitors that work by increasing the amount of insulin produced by the body after meals when blood sugar is high.
Which Other Drugs are DPP-4 Inhibitors?
In addition to Onglyza, other diabetes medications in the DPP-4 inhibitor class include:
- Januvia (sitagliptin)
- Janumet (sitagliptin and metformin)
- Janumet XR (sitagliptin and metformin extended release)
- Kombiglyze XR (saxagliptin and metformin extended release)
- Tradjenta (linagliptin)
- Glyxambi (linagliptin and empagliflozin)
- Jentadueto (linagliptin and metformin)
- Nesina (alogliptin)
- Kazano (alogliptin and metformin)
- Oseni (alogliptin and pioglitazone)
What’s the Problem?
Recent studies have found that Onglyza and other DPP-4 inhibitors may increase the risk of chronic pancreatitis, which may cause some users to develop pancreatic cancer. Other research has also indicated that there may be a link between Onglyza and heart failure.
Has Onglyza Been Recalled?
Despite being linked to pancreatitis, pancreatic cancer, heart failure and other serious side effects, Onglyza has not been recalled and continues to be prescribed to unsuspecting patients around the country. The U.S. Food & Drug Administration (FDA) issues recalls only after medications are found to be defective or potentially harmful. This often takes many years and adverse event reports from the public.
Is There a Class Action?
No class action lawsuit has been filed to date in the Onglyza litigation. However, our lawyers are reviewing potential individual suits for people who were injured by the medication. We specialize in helping victims of defective drugs file lawsuits against companies who sell dangerous medications, fail to warn about side effects, and put corporate profits above public safety. If you were injured by Onglyza and we determine that you have a legitimate claim against AstraZeneca, you may be eligible to receive compensation for your pain and suffering, medical expenses, permanent disability, lost income, decreased quality of life and more.
Which Injuries is your Firm Accepting?
Our law firm is accepting potential lawsuits on behalf of individuals who suffered the following injuries after taking Onglyza:
- Pancreatic cancer
- Heart failure
- Wrongful death
What are Onglyza Lawsuits Alleging?
Previously filed Onglyza lawsuits have alleged that AstraZeneca:
- Failed to perform adequate pre-market trials;
- Failed to warn the public and medical community about the potential health risks of Onglyza;
- Fraudulently and/or negligently marketed the drug, and
- Marketed Onglyza despite having knowledge of its serious side effects.
Are Cases Being Settled?
The Onglyza litigation is still in its early stages, and AstraZeneca has not yet made any significant settlement offers. However, the nature of the lawsuits and growing number of complaints filed over the drug would suggest a settlement agreement at some point in the future.
You may be eligible to participate in an Onglyza lawsuit if you believe that you or a family member was injured by the drug’s side effects. These settlements will likely provide compensation for medical expenses, lost wages, pain and suffering, and other damages.
How Much Does it Cost to File a Lawsuit?
All cases are reviewed by our law firm under a contingency fee agreement, which means that you pay nothing unless we achieve a favorable outcome in your case. Each case does have a state-imposed deadline, or statute of limitations (SOL), which requires that your lawsuit must be filed by a certain date. Therefore, it is important that you contact an attorney as soon as possible if you feel you have a case. Waiting to do so could bar you from the ability to receive compensation for your injuries.